BCRX — BioCryst Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.05bn
- $2.52bn
- $874.84m
Brief: Biocryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Biocryst Announces Sale Of European Orladeyo(Berotralstat) Business To Neopharmed Gentili For Up To $264 Million
Brief: Biocryst Pharmaceuticals: FDA Extends PDUFA Goal Date For Orladeyo NDA
Brief: Biocryst Announces FDA Acceptance Of NDA For Orladeyo (Berotralstat) Oral Granules In Patients With Hereditary Angioedema Aged 2 To 11 Years
U.S. STOCKS ON THE MOVE-Wendy's, Skechers, Reddit
U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers
BioCryst Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Stardust Power, Peabody, On Semiconductor
BioCryst Pharma rises after lifting annual sales forecast for skin disease drug
Brief: Biocryst Reports Inducement Grants Under Nasdaq Listing Rule
Brief: Biocryst Pharmaceuticals Appoints Jon Stonehouse As Interim CFO & Interim Principal Accounting Officer - SEC Filing
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
U.S. STOCKS ON THE MOVE-BankUnited, Hesai Group, Sezzle
BioCryst takes legal action to defend rare genetic drug patent; shares fall
Brief: Biocryst Pharmaceuticals - On March 10, Files Patent Infringement Lawsuit Against Annora And Other Co's
Brief: Biocryst Pharmaceuticals Says CFO Anthony Doyle To Resign Effective April 9, 2025
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot
U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities
BioCryst falls on wider-than-expected quarterly loss